Biotech Investors & VC Firms in New York
143 firms in this list, with a median first check of $500K. 31 of them lead rounds. Generated from verified public data and updated continuously.
Bain Capital Life Sciences
BostonSeries B–Late Stage
47 people
Artesian
SydneyPre-Seed–Late Stage$20M
39 people
Cerity Partners Ventures
BostonSeed–Late Stage
21 people
Berkeley Frontier
BerkeleyPre-Seed–Late Stage
41 people
Jeito Capital
Paris
39 people
ARCHIMED Japan
LyonGrowth–Late Stage$10.8M – $1.1B
22 people
HCVC
ParisPre-Seed–Series A$100K – $1M
6 people
Vibe Capital
San FranciscoPre-Seed–Series A$250K – $500K
3 people
Amulet Capital Partners, LP
Greenwich
32 people
SteelSky Ventures
AtlantaSeed$100K – $5M
11 people
Enterprise Investors Sp. z o. o.
WarsawSeries A–Growth$21.6M – $81M
31 people
Creator Fund
LondonPre-Seed–Series A$1.1M
20 people
America's Frontier Fund
ArlingtonPre-Seed–Growth$500K – $10M
14 people
Logos
San FranciscoSeries A–Series B
20 people
Kinled Holding
Hong KongSeed–Series A
1 person
MC Healthcare Ventures
CambridgeSeed–Series A
6 people
Partnership Fund for NYC
New York CitySeed–Growth
10 people
Tetragon Financial Group Limited
LondonSeries C
12 people
Helios Capital
MiamiPre-Seed–Series A$25K – $1M
2 people
PFM Health Sciences
San Francisco
9 people
Ridgeback Capital
MiamiSeed–Late Stage
1 person
Seldor Capital
New York CitySeed–Series A
6 people
Braidwell
Stamford
9 people
Related lists
Investors & VC Firms in North America (13845)Investors & VC Firms in United States (12980)Investors & VC Firms in Europe (5528)Crypto & Web3 Investors & VC Firms (4819)Investors & VC Firms in Global (4182)SaaS Investors & VC Firms (3878)AI & Machine Learning Investors & VC Firms (3817)Fintech Investors & VC Firms (3737)Investors & VC Firms in Asia-Pacific (3575)Healthtech Investors & VC Firms (3445)
Data sourced from public filings and firms' own websites — see our methodology.




















































































